API
< Back to situations

[ORGANIZATION]

OrigAMI-4 trial

Featured in 1 tracked story · first seen

Situations

[ACTIVE] [HEALTH] [DE] [US]

Johnson & Johnson oncology clinical developments

2 clusters · 3 sources · last updated

Latest: Johnson & Johnson receives FDA accelerated approval for Rybrevant Faspro

Johnson & Johnson reported positive results from several oncology clinical trials. Data presented at the European Society for Medical Oncology Congress indicated that the drug Erleada, when used in combination with andro